The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc. ("EPS"): | | | | | | | | | | | | | | | | | | | (in millions, except per share amounts) | 2026 | | 2025 | | 2024 | Net earnings | $ | 1,705 | | | $ | 1,569 | | | $ | 853 | | | Net earnings attributable to noncontrolling interest | 9 | | | (8) | | | (1) | | | | | | | | | | | | | | Net earnings attributable to Cardinal Health, Inc. | $ | 1,714 | | | $ | 1,561 | | | $ | 852 | | | Weighted-average common shares–basic | 236 | | | 241 | | | 245 | | | Effect of dilutive securities: | | | | | | Employee stock options, restricted share units, and performance share units | 1 | | | 1 | | | 2 | | | Weighted-average common shares–diluted | 237 | | | 242 | | | 247 | | Basic earnings per common share attributable to Cardinal Health, Inc.: | $ | 7.27 | | | $ | 6.48 | | | $ | 3.48 | | | | | | | | | | | | | | | | | | | | | | | | | | Diluted earnings per common share attributable to Cardinal Health, Inc.: | 7.23 | | | 6.45 | | | 3.45 | | | | | | | | | | | | | | | | | | | |
|